{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ALS disease", "Alzheimer\u2019s disease", "Huntington\u2019s disease", "Parkinson\u2019 s disease", "Withania somnifera (L.) Dunal", "withanolides"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38592845", "DateRevised": {"Year": "2024", "Month": "04", "Day": "11"}, "Article": {"Language": ["eng"], "ELocationID": ["771", "10.3390/plants13060771"], "ArticleDate": [{"Year": "2024", "Month": "03", "Day": "08"}], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "13", "Issue": "6", "PubDate": {"Year": "2024", "Month": "Mar", "Day": "08"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "<i>Withania somnifera</i> (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review.", "Abstract": {"AbstractText": ["<i>Withania somnifera</i> (L.) Dunal is a medicinal plant belonging to the traditional Indian medical system, showing various therapeutic effects such as anti-cancer, anti-inflammatory, anti-microbial, anti-diabetic, and hepatoprotective activity. Of great interest is <i>W. somnifera</i>'s potential beneficial effect against neurodegenerative diseases, since the authorized medicinal treatments can only delay disease progression and provide symptomatic relief and are not without side effects. A systematic search of PubMed and Scopus databases was performed to identify preclinical and clinical studies focusing on the applications of <i>W. somnifera</i> in preventing neurodegenerative diseases. Only English articles and those containing the keywords (<i>Withania somnifera</i> AND \"neurodegenerative diseases\", \"neuroprotective effects\", \"Huntington\", \"Parkinson\", \"Alzheimer\", \"Amyotrophic Lateral Sclerosis\", \"neurological disorders\") in the title or abstract were considered. Reviews, editorials, letters, meta-analyses, conference papers, short surveys, and book chapters were not considered. Selected articles were grouped by pathologies and summarized, considering the mechanism of action. The quality assessment and the risk of bias were performed using the Cochrane Handbook for Systematic Reviews of Interventions checklist. This review uses a systematic approach to summarize the results from 60 investigations to highlight the potential role of <i>W. somnifera</i> and its specialized metabolites in treating or preventing neurodegenerative diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Science, University of Basilicata, V.le Ateneo Lucano 10, 85100 Potenza, Italy."}], "LastName": "Lerose", "ForeName": "Valentina", "Initials": "V"}, {"Identifier": ["0000-0002-2145-0284"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Science, University of Basilicata, V.le Ateneo Lucano 10, 85100 Potenza, Italy."}], "LastName": "Ponticelli", "ForeName": "Maria", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Science, University of Basilicata, V.le Ateneo Lucano 10, 85100 Potenza, Italy."}], "LastName": "Benedetto", "ForeName": "Nadia", "Initials": "N"}, {"Identifier": ["0009-0002-3954-0170"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Science, University of Basilicata, V.le Ateneo Lucano 10, 85100 Potenza, Italy."}], "LastName": "Carlucci", "ForeName": "Vittorio", "Initials": "V"}, {"Identifier": ["0000-0001-7011-7288"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Science, University of Basilicata, V.le Ateneo Lucano 10, 85100 Potenza, Italy."}], "LastName": "Lela", "ForeName": "Ludovica", "Initials": "L"}, {"Identifier": ["0000-0002-8482-0481"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Molecular Biology \"Roumen Tsanev\", Department of Biochemical Pharmacology & Drug Design, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 21, 1113 Sofia, Bulgaria."}], "LastName": "Tzvetkov", "ForeName": "Nikolay T", "Initials": "NT"}, {"Identifier": ["0000-0002-5874-1237"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Science, University of Basilicata, V.le Ateneo Lucano 10, 85100 Potenza, Italy."}], "LastName": "Milella", "ForeName": "Luigi", "Initials": "L"}], "GrantList": [{"GrantID": "CUP: B34I20000320005", "Agency": "Project RESO - REsilienza e SOstenibilit\u00e0 delle filiere ortofrutticole e cerealicole per valorizzare i territori\" - cod. identif. ARS01_01224 -", "Country": ""}, {"GrantID": "CUP: G49J19001350004", "Agency": "Project SPIA-Valorization of by-products from the agro-food chain", "Country": ""}, {"GrantID": "CUP: ECS00000036", "Agency": "Project NODES - Ecosistema dell'Innovazione \"Nord Ovest Digitale e Sostenibile\"", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Balkrishna A., Misra L. Chemo-botanical and neurological accounts of some ayurvedic plants useful in mental health. Nat. Prod. 2018;8:14\u201331. doi: 10.2174/2210315507666170616082903.", "ArticleIdList": ["10.2174/2210315507666170616082903"]}, {"Citation": "Ahmad M., Dar N. Withania somnifera: Ethnobotany, pharmacology, and therapeutic functions in sustained energy for enhanced human functions and activity. Sustain. Energy Enhanc. Hum. Funct. Act. 2017:137\u2013154. doi: 10.1016/B978-0-12-805413-0.00008-9.", "ArticleIdList": ["10.1016/B978-0-12-805413-0.00008-9"]}, {"Citation": "Dar N.J., Hamid A., Ahmad M. Pharmacologic overview of Withania somnifera, the Indian Ginseng. Cell. Mol. Life Sci. 2015;72:4445\u20134460. doi: 10.1007/s00018-015-2012-1.", "ArticleIdList": ["10.1007/s00018-015-2012-1", "26306935"]}, {"Citation": "Kulkarni S.K., Dhir A. Withania somnifera: An Indian ginseng. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2008;32:1093\u20131105. doi: 10.1016/j.pnpbp.2007.09.011.", "ArticleIdList": ["10.1016/j.pnpbp.2007.09.011", "17959291"]}, {"Citation": "Behl T., Sharma A., Sharma L., Sehgal A., Zengin G., Brata R., Fratila O., Bungau S. Exploring the multifaceted therapeutic potential of withaferin A and its derivatives. Biomedicines. 2020;8:571. doi: 10.3390/biomedicines8120571.", "ArticleIdList": ["10.3390/biomedicines8120571", "PMC7762146", "33291236"]}, {"Citation": "Logie E., Vanden Berghe W. Tackling Chronic Inflammation with Withanolide Phytochemicals-A Withaferin a Perspective. Antioxidants. 2020;9:1107. doi: 10.3390/antiox9111107.", "ArticleIdList": ["10.3390/antiox9111107", "PMC7696210", "33182809"]}, {"Citation": "Mandlik Ingawale D.S., Namdeo A.G. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects. J. Diet. Suppl. 2021;18:183\u2013226. doi: 10.1080/19390211.2020.1741484.", "ArticleIdList": ["10.1080/19390211.2020.1741484", "32242751"]}, {"Citation": "Mabberley D.J. Mabberley\u2019s Plant-Book: A Portable Dictionary of Plants, Their Classification and Uses. Cambridge University Press; Cambridge, UK: 2017."}, {"Citation": "Mirjalili M.H., Moyano E., Bonfill M., Cusido R.M., Palaz\u00f3n J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules. 2009;14:2373\u20132393. doi: 10.3390/molecules14072373.", "ArticleIdList": ["10.3390/molecules14072373", "PMC6255378", "19633611"]}, {"Citation": "Uddin Q., Samiulla L., Singh V., Jamil S. Phytochemical and pharmacological profile of Withania somnifera Dunal: A review. J. Appl. Pharm. Sci. 2012:170\u2013175."}, {"Citation": "Singh N., Bhalla M., de Jager P., Gilca M. An overview on ashwagandha: A Rasayana (rejuvenator) of Ayurveda. Afr. J. Tradit. Complement. Altern. Med. 2011;8:208\u2013213. doi: 10.4314/ajtcam.v8i5S.9.", "ArticleIdList": ["10.4314/ajtcam.v8i5S.9", "PMC3252722", "22754076"]}, {"Citation": "Reed T.T. Lipid peroxidation and neurodegenerative disease. Free Radic. Biol. Med. 2011;51:1302\u20131319. doi: 10.1016/j.freeradbiomed.2011.06.027.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.06.027", "21782935"]}, {"Citation": "Zuo L., Zhou T., Pannell B.K., Ziegler A.C., Best T.M. Biological and physiological role of reactive oxygen species\u2014The good, the bad and the ugly. Acta Physiol. 2015;214:329\u2013348. doi: 10.1111/apha.12515.", "ArticleIdList": ["10.1111/apha.12515", "25912260"]}, {"Citation": "Lela L., Russo D., De Biasio F., Gorgoglione D., Ostuni A., Ponticelli M., Milella L. Solanum aethiopicum L. from the Basilicata Region Prevents Lipid Absorption, Fat Accumulation, Oxidative Stress, and Inflammation in OA-Treated HepG2 and Caco-2 Cell Lines. Plants. 2023;12:2859. doi: 10.3390/plants12152859.", "ArticleIdList": ["10.3390/plants12152859", "PMC10421219", "37571013"]}, {"Citation": "Liu Z., Zhou T., Ziegler A.C., Dimitrion P., Zuo L. Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications. Oxid. Med. Cell. Longev. 2017;2017:2525967. doi: 10.1155/2017/2525967.", "ArticleIdList": ["10.1155/2017/2525967", "PMC5529664", "28785371"]}, {"Citation": "Dhar R.S., Verma V., Suri K.A., Sangwan R.S., Satti N.K., Kumar A., Tuli R., Qazi G.N. Phytochemical and genetic analysis in selected chemotypes of Withania somnifera. Phytochemistry. 2006;67:2269\u20132276. doi: 10.1016/j.phytochem.2006.07.014.", "ArticleIdList": ["10.1016/j.phytochem.2006.07.014", "16956635"]}, {"Citation": "Chatterjee S., Srivastava S., Khalid A., Singh N., Sangwan R.S., Sidhu O.P., Roy R., Khetrapal C., Tuli R. Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extracts. Phytochemistry. 2010;71:1085\u20131094. doi: 10.1016/j.phytochem.2010.04.001.", "ArticleIdList": ["10.1016/j.phytochem.2010.04.001", "20483437"]}, {"Citation": "Xu Y.M., Gao S., Bunting D.P., Gunatilaka A.A. Unusual withanolides from aeroponically grown Withania somnifera. Phytochemistry. 2011;72:518\u2013522. doi: 10.1016/j.phytochem.2010.12.020.", "ArticleIdList": ["10.1016/j.phytochem.2010.12.020", "21315384"]}, {"Citation": "Saleem S., Muhammad G., Hussain M.A., Altaf M., Bukhari S.N.A. Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective. Iran. J. Basic Med. Sci. 2020;23:1501\u20131526. doi: 10.22038/ijbms.2020.44254.10378.", "ArticleIdList": ["10.22038/ijbms.2020.44254.10378", "PMC7811807", "33489024"]}, {"Citation": "Ghoshal S., Ghule C., Mirgal A., Girme A., Hingorani L. Recent findings by high-performance thin-layer chromatographic separation for a comprehensive analysis of Withania somnifera by densitometry and mass spectrometry: An assessment to quality and adulteration. JPC J. Planar Chromatogr. Mod. TLC. 2022;35:439\u2013451. doi: 10.1007/s00764-022-00187-z.", "ArticleIdList": ["10.1007/s00764-022-00187-z"]}, {"Citation": "Saini D., Madan K., Chauhan S. Screening of Phytoconstituents from Traditional Plants against SARSCoV-2 using Molecular Docking Approach. Lett. Drug Des. Discov. 2022;19:1022\u20131038. doi: 10.2174/1570180819666220307163058.", "ArticleIdList": ["10.2174/1570180819666220307163058"]}, {"Citation": "Kuboyama T., Tohda C., Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration. Eur. J. Neurosci. 2006;23:1417\u20131426. doi: 10.1111/j.1460-9568.2006.04664.x.", "ArticleIdList": ["10.1111/j.1460-9568.2006.04664.x", "16553605"]}, {"Citation": "Matsuda H., Murakami T., Kishi A., Yoshikawa M. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg. Med. Chem. 2001;9:1499\u20131507. doi: 10.1016/S0968-0896(01)00024-4.", "ArticleIdList": ["10.1016/S0968-0896(01)00024-4", "11408168"]}, {"Citation": "Jayaprakasam B., Strasburg G.A., Nair M.G. Potent lipid peroxidation inhibitors from Withania somnifera fruits. Tetrahedron. 2004;60:3109\u20133121. doi: 10.1016/j.tet.2004.01.016.", "ArticleIdList": ["10.1016/j.tet.2004.01.016"]}, {"Citation": "Kapoor L. Handbook of Ayurvedic Medicinal Plants. CRC Press Inc.; Boca Raton, FL, USA: 1990."}, {"Citation": "Misra L., Mishra P., Pandey A., Sangwan R.S., Sangwan N.S., Tuli R. Withanolides from Withania somnifera roots. Phytochemistry. 2008;69:1000\u20131004. doi: 10.1016/j.phytochem.2007.10.024.", "ArticleIdList": ["10.1016/j.phytochem.2007.10.024", "18061221"]}, {"Citation": "Dubey S., Kallubai M., Sarkar A., Subramanyam R. Elucidating the active interaction mechanism of phytochemicals withanolide and withanoside derivatives with human serum albumin. PLoS ONE. 2018;13:e0200053. doi: 10.1371/journal.pone.0200053.", "ArticleIdList": ["10.1371/journal.pone.0200053", "PMC6221254", "30403672"]}, {"Citation": "Dubey S., Kallubai M., Subramanyam R. Improving the inhibition of \u03b2-amyloid aggregation by withanolide and withanoside derivatives. Int. J. Biol. Macromol. 2021;173:56\u201365. doi: 10.1016/j.ijbiomac.2021.01.094.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.01.094", "33465364"]}, {"Citation": "Gupta A.P., Verma R.K., Misra H.O., Gupta M.M. Quantitative determination of withanferin-A in different plant parts of Withania somnifera by TLC densitometry. J. Med. Aromat. Plant Sci. 1996;18:788\u2013790."}, {"Citation": "Ganzera M., Choudhary M., Khan I. Quantitative HPLC analysis of withanolides in Withania somnifera. Fitoterapia. 2003;74:68\u201376. doi: 10.1016/S0367-326X(02)00325-8.", "ArticleIdList": ["10.1016/S0367-326X(02)00325-8", "12628397"]}, {"Citation": "Pandey A., Bani S., Dutt P., Kumar Satti N., Avtar Suri K., Nabi Qazi G. Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction. Cytokine. 2018;102:211\u2013221. doi: 10.1016/j.cyto.2017.10.019.", "ArticleIdList": ["10.1016/j.cyto.2017.10.019", "29108796"]}, {"Citation": "Jayaprakasam B., Padmanabhan K., Nair M.G. Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer\u2019s disease. Phytother. Res. PTR. 2010;24:859\u2013863. doi: 10.1002/ptr.3033.", "ArticleIdList": ["10.1002/ptr.3033", "19957250"]}, {"Citation": "Kuboyama T., Tohda C., Zhao J., Nakamura N., Hattori M., Komatsu K. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuroreport. 2002;13:1715\u20131720. doi: 10.1097/00001756-200210070-00005.", "ArticleIdList": ["10.1097/00001756-200210070-00005", "12395110"]}, {"Citation": "Arshad Jamal S., Iqbal Choudhary M. Two new withanolides from Withania somnifera. Heterocycles. 1992;34:689\u2013698. doi: 10.3987/COM-91-5791.", "ArticleIdList": ["10.3987/COM-91-5791"]}, {"Citation": "Benedetto N., Carlucci V., Faraone I., Lela L., Ponticelli M., Russo D., Mangieri C., Tzvetkov N.T., Milella L. An Insight into Citrus medica Linn.: A Systematic Review on Phytochemical Profile and Biological Activities. Plants. 2023;12:2267. doi: 10.3390/plants12122267.", "ArticleIdList": ["10.3390/plants12122267", "PMC10301705", "37375892"]}, {"Citation": "Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int. J. Surg. 2021;88:105906. doi: 10.1016/j.ijsu.2021.105906.", "ArticleIdList": ["10.1016/j.ijsu.2021.105906", "33789826"]}, {"Citation": "Du X., Wang X., Geng M. Alzheimer\u2019s disease hypothesis and related therapies. Transl. Neurodegener. 2018;7:2. doi: 10.1186/s40035-018-0107-y.", "ArticleIdList": ["10.1186/s40035-018-0107-y", "PMC5789526", "29423193"]}, {"Citation": "Sharma P., Srivastava P., Seth A., Tripathi P.N., Banerjee A.G., Shrivastava S.K. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies. Prog. Neurobiol. 2019;174:53\u201389. doi: 10.1016/j.pneurobio.2018.12.006.", "ArticleIdList": ["10.1016/j.pneurobio.2018.12.006", "30599179"]}, {"Citation": "Kinney J.W., Bemiller S.M., Murtishaw A.S., Leisgang A.M., Salazar A.M., Lamb B.T. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2018;4:575\u2013590. doi: 10.1016/j.trci.2018.06.014.", "ArticleIdList": ["10.1016/j.trci.2018.06.014", "PMC6214864", "30406177"]}, {"Citation": "Grodzicki W., Dziendzikowska K. The Role of Selected Bioactive Compounds in the Prevention of Alzheimer\u2019s Disease. Antioxidants. 2020;9:229. doi: 10.3390/antiox9030229.", "ArticleIdList": ["10.3390/antiox9030229", "PMC7139322", "32168776"]}, {"Citation": "Yiannopoulou K.G., Papageorgiou S.G. Current and Future Treatments in Alzheimer Disease: An Update. J. Cent. Nerv. Syst. Dis. 2020;12:1179573520907397. doi: 10.1177/1179573520907397.", "ArticleIdList": ["10.1177/1179573520907397", "PMC7050025", "32165850"]}, {"Citation": "Dickson T.C., Vickers J.C. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer\u2019s disease. Neuroscience. 2001;105:99\u2013107. doi: 10.1016/S0306-4522(01)00169-5.", "ArticleIdList": ["10.1016/S0306-4522(01)00169-5", "11483304"]}, {"Citation": "Perl D.P. Neuropathology of Alzheimer\u2019s disease. Mt. Sinai J. Med. J. Transl. Pers. Med. 2010;77:32\u201342. doi: 10.1002/msj.20157.", "ArticleIdList": ["10.1002/msj.20157", "PMC2918894", "20101720"]}, {"Citation": "Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991;30:572\u2013580. doi: 10.1002/ana.410300410.", "ArticleIdList": ["10.1002/ana.410300410", "1789684"]}, {"Citation": "Tohda C., Kuboyama T., Komatsu K. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells. Neuroreport. 2000;11:1981\u20131985. doi: 10.1097/00001756-200006260-00035.", "ArticleIdList": ["10.1097/00001756-200006260-00035", "10884056"]}, {"Citation": "Zhao J., Nakamura N., Hattori M., Kuboyama T., Tohda C., Komatsu K. Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem. Pharm. Bull. 2002;50:760\u2013765. doi: 10.1248/cpb.50.760.", "ArticleIdList": ["10.1248/cpb.50.760", "12045329"]}, {"Citation": "Kuboyama T., Tohda C., Komatsu K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br. J. Pharmacol. 2005;144:961\u2013971. doi: 10.1038/sj.bjp.0706122.", "ArticleIdList": ["10.1038/sj.bjp.0706122", "PMC1576076", "15711595"]}, {"Citation": "Joyashiki E., Matsuya Y., Tohda C. Sominone improves memory impairments and increases axonal density in Alzheimer\u2019s disease model mice, 5XFAD. Int. J. Neurosci. 2011;121:181\u2013190. doi: 10.3109/00207454.2010.541571.", "ArticleIdList": ["10.3109/00207454.2010.541571", "21329473"]}, {"Citation": "Tohda C., Joyashiki E. Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET. Br. J. Pharmacol. 2009;157:1427\u20131440. doi: 10.1111/j.1476-5381.2009.00313.x.", "ArticleIdList": ["10.1111/j.1476-5381.2009.00313.x", "PMC2765306", "19594760"]}, {"Citation": "Patil S.P., Maki S., Khedkar S.A., Rigby A.C., Chan C. Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance. J. Nat. Prod. 2010;73:1196\u20131202. doi: 10.1021/np900633j.", "ArticleIdList": ["10.1021/np900633j", "PMC2917495", "20553006"]}, {"Citation": "Prox J., Rittger A., Saftig P. Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and presenilin. Exp. Brain Res. 2012;217:331\u2013341. doi: 10.1007/s00221-011-2952-0.", "ArticleIdList": ["10.1007/s00221-011-2952-0", "22120156"]}, {"Citation": "Afewerky H.K., Li H., Zhang T., Li X., Mahaman Y.A.R., Duan L., Qin P., Zheng J., Pei L., Lu Y. Sodium\u2013calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer\u2019s disease. Sci. Rep. 2022;12:1537. doi: 10.1038/s41598-022-05568-2.", "ArticleIdList": ["10.1038/s41598-022-05568-2", "PMC8795410", "35087161"]}, {"Citation": "Green K.N. Calcium in the initiation, progression and as an effector of Alzheimer\u2019s disease pathology. J. Cell. Mol. Med. 2009;13:2787\u20132799. doi: 10.1111/j.1582-4934.2009.00861.x.", "ArticleIdList": ["10.1111/j.1582-4934.2009.00861.x", "PMC4498936", "19650832"]}, {"Citation": "Kurapati K.R., Atluri V.S., Samikkannu T., Nair M.P. Ashwagandha (Withania somnifera) reverses \u03b2-amyloid1-42 induced toxicity in human neuronal cells: Implications in HIV-associated neurocognitive disorders (HAND) PLoS ONE. 2013;8:e77624. doi: 10.1371/journal.pone.0077624.", "ArticleIdList": ["10.1371/journal.pone.0077624", "PMC3797707", "24147038"]}, {"Citation": "Kurapati K.R., Samikkannu T., Atluri V.S., Kaftanovskaya E., Yndart A., Nair M.P. \u03b2-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A. PLoS ONE. 2014;9:e112818. doi: 10.1371/journal.pone.0112818.", "ArticleIdList": ["10.1371/journal.pone.0112818", "PMC4240587", "25415340"]}, {"Citation": "Maria M., Thimmappa S., Edward H., Byung S., Joseph Q., Reddy P. Mitochondria are a direct site of A\u00df accumulation in Alzheimer\u2019s disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 2006;15:1437\u20131449. doi: 10.1093/hmg/ddl066.", "ArticleIdList": ["10.1093/hmg/ddl066", "16551656"]}, {"Citation": "Mohamed A., Posse de Chaves E. A\u03b2 internalization by neurons and glia. Int. J. Alzheimer\u2019s Dis. 2011;2011:127984. doi: 10.4061/2011/127984.", "ArticleIdList": ["10.4061/2011/127984", "PMC3042623", "21350608"]}, {"Citation": "Mandrekar-Colucci S., Karlo J.C., Landreth G.E. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-\u03b3-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer\u2019s disease. J. Neurosci. Off. J. Soc. Neurosci. 2012;32:10117\u201310128. doi: 10.1523/JNEUROSCI.5268-11.2012.", "ArticleIdList": ["10.1523/JNEUROSCI.5268-11.2012", "PMC3433721", "22836247"]}, {"Citation": "Kumar S., Seal C.J., Howes M.J., Kite G.C., Okello E.J. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and \u03b2-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells. Phytother. Res. PTR. 2010;24:1567\u20131574. doi: 10.1002/ptr.3261.", "ArticleIdList": ["10.1002/ptr.3261", "20680931"]}, {"Citation": "Stan S.D., Zeng Y., Singh S.V. Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr. Cancer. 2008;60((Suppl. 1)):51\u201360. doi: 10.1080/01635580802381477.", "ArticleIdList": ["10.1080/01635580802381477", "PMC2597540", "19003581"]}, {"Citation": "Harris J.R. In vitro fibrillogenesis of the amyloid beta 1-42 peptide: Cholesterol potentiation and aspirin inhibition. Micron. 2002;33:609\u2013626. doi: 10.1016/S0968-4328(02)00029-X.", "ArticleIdList": ["10.1016/S0968-4328(02)00029-X", "12475558"]}, {"Citation": "Harris J.R. Cholesterol binding to amyloid-beta fibrils: A TEM study. Micron. 2008;39:1192\u20131196. doi: 10.1016/j.micron.2008.05.001.", "ArticleIdList": ["10.1016/j.micron.2008.05.001", "18586500"]}, {"Citation": "Kumar S., Harris R.J., Seal C.J., Okello E.J. An aqueous extract of Withania somnifera root inhibits amyloid \u03b2 fibril formation in vitro. Phytother. Res. PTR. 2012;26:113\u2013117. doi: 10.1002/ptr.3512.", "ArticleIdList": ["10.1002/ptr.3512", "21567509"]}, {"Citation": "Tiwari S., Atluri V.S.R., Yndart Arias A., Jayant R.D., Kaushik A., Geiger J., Nair M.N. Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions. Front. Aging Neurosci. 2018;10:291. doi: 10.3389/fnagi.2018.00291.", "ArticleIdList": ["10.3389/fnagi.2018.00291", "PMC6190869", "30356847"]}, {"Citation": "Atluri V.S.R., Tiwari S., Rodriguez M., Kaushik A., Yndart A., Kolishetti N., Yatham M., Nair M. Inhibition of Amyloid-Beta production, associated neuroinflammation, and Histone Deacetylase 2-mediated epigenetic modifications prevent neuropathology in Alzheimer\u2019s disease in vitro Model. Front. Aging Neurosci. 2020;11:342. doi: 10.3389/fnagi.2019.00342.", "ArticleIdList": ["10.3389/fnagi.2019.00342", "PMC6974446", "32009938"]}, {"Citation": "Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L. Inflammation and Alzheimer\u2019s disease. Neurobiol. Aging. 2000;21:383\u2013421. doi: 10.1016/S0197-4580(00)00124-X.", "ArticleIdList": ["10.1016/S0197-4580(00)00124-X", "PMC3887148", "10858586"]}, {"Citation": "Bonaiuto C., McDonald P.P., Rossi F., Cassatella M.A. Activation of nuclear factor-\u03baB by \u03b2-amyloid peptides and interferon-\u03b3 in murine microglia. J. Neuroimmunol. 1997;77:51\u201356. doi: 10.1016/S0165-5728(97)00054-4.", "ArticleIdList": ["10.1016/S0165-5728(97)00054-4", "9209268"]}, {"Citation": "Agostinho P., Cunha R.A., Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Curr. Pharm. Des. 2010;16:2766\u20132778. doi: 10.2174/138161210793176572.", "ArticleIdList": ["10.2174/138161210793176572", "20698820"]}, {"Citation": "Cameron B., Landreth G.E. Inflammation, microglia, and Alzheimer\u2019s disease. Neurobiol. Dis. 2010;37:503\u2013509. doi: 10.1016/j.nbd.2009.10.006.", "ArticleIdList": ["10.1016/j.nbd.2009.10.006", "PMC2823849", "19833208"]}, {"Citation": "Mandrekar-Colucci S., Landreth G.E. Microglia and inflammation in Alzheimer\u2019s disease. J. CNS Neurol. Disord.-Drug Targets. 2010;9:156\u2013167. doi: 10.2174/187152710791012071.", "ArticleIdList": ["10.2174/187152710791012071", "PMC3653290", "20205644"]}, {"Citation": "Heneka M.T., Kummer M.P., Stutz A., Delekate A., Schwartz S., Vieira-Saecker A., Griep A., Axt D., Remus A., Tzeng T.C., et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493:674\u2013678. doi: 10.1038/nature11729.", "ArticleIdList": ["10.1038/nature11729", "PMC3812809", "23254930"]}, {"Citation": "Heyninck K., Lahtela-Kakkonen M., Van der Veken P., Haegeman G., Vanden Berghe W. Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKK\u03b2. Biochem. Pharmacol. 2014;91:501\u2013509. doi: 10.1016/j.bcp.2014.08.004.", "ArticleIdList": ["10.1016/j.bcp.2014.08.004", "25159986"]}, {"Citation": "Martorana F., Guidotti G., Brambilla L., Rossi D. Withaferin A inhibits nuclear factor-\u03baB-dependent pro-inflammatory and stress response pathways in the astrocytes. J. Neural Plast. 2015;2015:381964. doi: 10.1155/2015/381964.", "ArticleIdList": ["10.1155/2015/381964", "PMC4523683", "26266054"]}, {"Citation": "Sehgal N., Gupta A., Valli R.K., Joshi S.D., Mills J.T., Hamel E., Khanna P., Jain S.C., Thakur S.S., Ravindranath V. Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. USA. 2012;109:3510\u20133515. doi: 10.1073/pnas.1112209109.", "ArticleIdList": ["10.1073/pnas.1112209109", "PMC3295277", "22308347"]}, {"Citation": "Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., et al. Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Investig. 2000;106:1489\u20131499. doi: 10.1172/JCI10498.", "ArticleIdList": ["10.1172/JCI10498", "PMC387254", "11120756"]}, {"Citation": "Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., Xu F., Parisi M., LaRue B., Hu H.W., et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron. 2004;43:333\u2013344. doi: 10.1016/j.neuron.2004.07.017.", "ArticleIdList": ["10.1016/j.neuron.2004.07.017", "15294142"]}, {"Citation": "Ellis J.R., Ellis K.A., Bartholomeusz C.F., Harrison B.J., Wesnes K.A., Erskine F.F., Vitetta L., Nathan P.J. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int. J. Neuropsychopharmacol. 2006;9:175\u2013189. doi: 10.1017/S1461145705005407.", "ArticleIdList": ["10.1017/S1461145705005407", "15877932"]}, {"Citation": "Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies. Neurosci. Biobehav. Rev. 2010;34:1307\u20131350. doi: 10.1016/j.neubiorev.2010.04.001.", "ArticleIdList": ["10.1016/j.neubiorev.2010.04.001", "20398692"]}, {"Citation": "Konar A., Shah N., Singh R., Saxena N., Kaul S.C., Wadhwa R., Thakur M.K. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS ONE. 2011;6:e27265. doi: 10.1371/journal.pone.0027265.", "ArticleIdList": ["10.1371/journal.pone.0027265", "PMC3214041", "22096544"]}, {"Citation": "Gautam A., Wadhwa R., Thakur M.K. Assessment of Cholinergic Properties of Ashwagandha Leaf-Extract in the Amnesic Mouse Brain. Ann. Neurosci. 2016;23:68\u201375. doi: 10.1159/000443573.", "ArticleIdList": ["10.1159/000443573", "PMC5020397", "27647956"]}, {"Citation": "Konar A., Gupta R., Shukla R.K., Maloney B., Khanna V.K., Wadhwa R., Lahiri D.K., Thakur M.K. M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera. Sci. Rep. 2019;9:13990. doi: 10.1038/s41598-019-48238-6.", "ArticleIdList": ["10.1038/s41598-019-48238-6", "PMC6769020", "31570736"]}, {"Citation": "Bhatnagar M., Suhalka P., Sukhwal P., Jain A., Sharma D. Inhibition of acetylcholinesterase and NO synthase activity in the mice brain: Effect of a Withania somnifera leaf juice. Neurophysiology. 2012;44:301\u2013308. doi: 10.1007/s11062-012-9300-2.", "ArticleIdList": ["10.1007/s11062-012-9300-2"]}, {"Citation": "Vinutha B., Prashanth D., Salma K., Sreeja S.L., Pratiti D., Padmaja R., Radhika S., Amit A., Venkateshwarlu K., Deepak M. Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J. Ethnopharmacol. 2007;109:359\u2013363. doi: 10.1016/j.jep.2006.06.014.", "ArticleIdList": ["10.1016/j.jep.2006.06.014", "16950584"]}, {"Citation": "Visweswari G., Christopher R., Rajendra W. Dose-dependent effect of Withania somnifera on the cholinergic system in scopolamine-induced alzheimer\u2019s disease in rats. Int. J. Pharm. Sci. Res. 2014;5:4240\u20134248. doi: 10.13040/IJPSR.0975-8232.5(10).4240-48.", "ArticleIdList": ["10.13040/IJPSR.0975-8232.5(10).4240-48"]}, {"Citation": "Hynd M.R., Scott H.L., Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease. Neurochem. Int. 2004;45:583\u2013595. doi: 10.1016/j.neuint.2004.03.007.", "ArticleIdList": ["10.1016/j.neuint.2004.03.007", "15234100"]}, {"Citation": "Dar N.J., Bhat J.A., Satti N.K., Sharma P.R., Hamid A., Ahmad M. Withanone, an active constituent from Withania somnifera, affords protection against NMDA-induced excitotoxicity in neuron-like cells. Mol. Neurobiol. 2017;54:5061\u20135073. doi: 10.1007/s12035-016-0044-7.", "ArticleIdList": ["10.1007/s12035-016-0044-7", "27541286"]}, {"Citation": "Sattler R., Charlton M.P., Hafner M., Tymianski M. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J. Neurochem. 1998;71:2349\u20132364. doi: 10.1046/j.1471-4159.1998.71062349.x.", "ArticleIdList": ["10.1046/j.1471-4159.1998.71062349.x", "9832133"]}, {"Citation": "Dar N.J., Satti N.K., Dutt P., Hamid A., Ahmad M. Attenuation of glutamate-induced excitotoxicity by withanolide-A in neuron-like cells: Role for PI3K/Akt/MAPK signaling pathway. Mol. Neurobiol. 2018;55:2725\u20132739. doi: 10.1007/s12035-017-0515-5.", "ArticleIdList": ["10.1007/s12035-017-0515-5", "28447311"]}, {"Citation": "Kataria H., Wadhwa R., Kaul S.C., Kaur G. Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS ONE. 2012;7:e37080. doi: 10.1371/journal.pone.0037080.", "ArticleIdList": ["10.1371/journal.pone.0037080", "PMC3351387", "22606332"]}, {"Citation": "Reich S.G., Savitt J.M. Parkinson\u2019s Disease. Med. Clin. N. Am. 2019;103:337\u2013350. doi: 10.1016/j.mcna.2018.10.014.", "ArticleIdList": ["10.1016/j.mcna.2018.10.014", "30704685"]}, {"Citation": "Puspita L., Chung S.Y., Shim J.W. Oxidative stress and cellular pathologies in Parkinson\u2019s disease. Mol. Brain. 2017;10:53. doi: 10.1186/s13041-017-0340-9.", "ArticleIdList": ["10.1186/s13041-017-0340-9", "PMC5706368", "29183391"]}, {"Citation": "Wang Q., Liu Y., Zhou J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl. Neurodegener. 2015;4:19. doi: 10.1186/s40035-015-0042-0.", "ArticleIdList": ["10.1186/s40035-015-0042-0", "PMC4603346", "26464797"]}, {"Citation": "Maxwell S.R. Prospects for the use of antioxidant therapies. Drugs. 1995;49:345\u2013361. doi: 10.2165/00003495-199549030-00003.", "ArticleIdList": ["10.2165/00003495-199549030-00003", "7774511"]}, {"Citation": "Bhattacharya S.K., Satyan K.S., Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J. Exp. Biol. 1997;35:236\u2013239.", "ArticleIdList": ["9332168"]}, {"Citation": "Jayawanth Manjunath M. Effect of Withania somnifera supplementation on rotenone-induced oxidative damage in cerebellum and striatum of the male mice brain. J. Cent. Nerv. Syst. Agents Med. Chem. 2013;13:43\u201356. doi: 10.2174/1871524911313010007.", "ArticleIdList": ["10.2174/1871524911313010007", "23092410"]}, {"Citation": "Manjunath M.J., Muralidhara Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster. J. Food Sci. Technol. 2015;52:1971\u20131981. doi: 10.1007/s13197-013-1219-0.", "ArticleIdList": ["10.1007/s13197-013-1219-0", "PMC4375188", "25829577"]}, {"Citation": "De Rose F., Marotta R., Poddighe S., Talani G., Catelani T., Setzu M.D., Solla P., Marrosu F., Sanna E., Kasture S. Functional and morphological correlates in the Drosophila LRRK2 loss-of-function model of Parkinson\u2019s disease: Drug effects of Withania somnifera (Dunal) administration. PLoS ONE. 2016;11:e0146140. doi: 10.1371/journal.pone.0146140.", "ArticleIdList": ["10.1371/journal.pone.0146140", "PMC4699764", "26727265"]}, {"Citation": "Wongtrakul J., Thongtan T., Kumrapich B., Saisawang C., Ketterman A.J. Neuroprotective effects of Withania somnifera in the SH-SY5Y Parkinson cell model. Heliyon. 2021;7:e08172. doi: 10.1016/j.heliyon.2021.e08172.", "ArticleIdList": ["10.1016/j.heliyon.2021.e08172", "PMC8569401", "34765761"]}, {"Citation": "Ahmad M., Saleem S., Ahmad A.S., Ansari M.A., Yousuf S., Hoda M.N., Islam F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum. Exp. Toxicol. 2005;24:137\u2013147. doi: 10.1191/0960327105ht509oa.", "ArticleIdList": ["10.1191/0960327105ht509oa", "15901053"]}, {"Citation": "Prakash J., Yadav S.K., Chouhan S., Singh S.P. Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism. Neurochem. Res. 2013;38:972\u2013980. doi: 10.1007/s11064-013-1005-4.", "ArticleIdList": ["10.1007/s11064-013-1005-4", "23430469"]}, {"Citation": "Prakash J., Chouhan S., Yadav S.K., Westfall S., Rai S.N., Singh S.P. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochem. Res. 2014;39:2527\u20132536. doi: 10.1007/s11064-014-1443-7.", "ArticleIdList": ["10.1007/s11064-014-1443-7", "25403619"]}, {"Citation": "Zang L.Y., Misra H.P. Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Biol. Chem. 1993;268:16504\u201316512. doi: 10.1016/S0021-9258(19)85448-0.", "ArticleIdList": ["10.1016/S0021-9258(19)85448-0", "8393868"]}, {"Citation": "Sankar S.R., Manivasagam T., Krishnamurti A., Ramanathan M. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: An analysis of behavioral and biochemical variables. Cell. Mol. Biol. Lett. 2007;12:473\u2013481. doi: 10.2478/s11658-007-0015-0.", "ArticleIdList": ["10.2478/s11658-007-0015-0", "PMC6275882", "17415533"]}, {"Citation": "Sankar S.R., Manivasagam T., Singh V.A., Krishnamurti A., Ramanathan M. Prophylatic efficacy of Withania somnifera against mptp induced parkinson\u2019s disease in mice. J. Cell Tissue Res. 2007;7:975."}, {"Citation": "RajaSankar S., Manivasagam T., Sankar V., Prakash S., Muthusamy R., Krishnamurti A., Surendran S. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson\u2019s disease model mouse. J. Ethnopharmacol. 2009;125:369\u2013373. doi: 10.1016/j.jep.2009.08.003.", "ArticleIdList": ["10.1016/j.jep.2009.08.003", "19666100"]}, {"Citation": "Rajasankar S., Manivasagam T., Surendran S. Ashwagandha leaf extract: A potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson\u2019s disease. Neurosci. Lett. 2009;454:11\u201315. doi: 10.1016/j.neulet.2009.02.044.", "ArticleIdList": ["10.1016/j.neulet.2009.02.044", "19429045"]}, {"Citation": "Dhanasekaran M., Uthayathas S., Karuppagounder S.S., Parameshwaran K., Suppiramaniam V., Ebadi M., Brown-Borg H.M. Ebselen effects on MPTP-induced neurotoxicity. Brain Res. 2006;1118:251\u2013254. doi: 10.1016/j.brainres.2006.08.020.", "ArticleIdList": ["10.1016/j.brainres.2006.08.020", "16956591"]}, {"Citation": "Surendran S., Rajasankar S. Parkinson\u2019s disease: Oxidative stress and therapeutic approaches. Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 2010;31:531\u2013540. doi: 10.1007/s10072-010-0245-1.", "ArticleIdList": ["10.1007/s10072-010-0245-1", "20221655"]}, {"Citation": "Halliwell B. Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment. Drugs Aging. 2001;18:685\u2013716. doi: 10.2165/00002512-200118090-00004.", "ArticleIdList": ["10.2165/00002512-200118090-00004", "11599635"]}, {"Citation": "Koutsilieri E., Scheller C., Gr\u00fcnblatt E., Nara K., Li J., Riederer P. Free radicals in Parkinson\u2019s disease. Neurology. 2002;249:ii01\u2013ii05. doi: 10.1007/s00415-002-1201-7.", "ArticleIdList": ["10.1007/s00415-002-1201-7", "12375056"]}, {"Citation": "Blum D., Torch S., Lambeng N., Nissou M.-F., Benabid A.-L., Sadoul R., Verna J.-M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson\u2019s disease. Prog. Neurobiol. 2001;65:135\u2013172. doi: 10.1016/S0301-0082(01)00003-X.", "ArticleIdList": ["10.1016/S0301-0082(01)00003-X", "11403877"]}, {"Citation": "Yang L., Matthews R.T., Schulz J.B., Klockgether T., Liao A.W., Martinou J.C., Penney J.B., Jr., Hyman B.T., Beal M.F. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J. Neurosci. Off. J. Soc. Neurosci. 1998;18:8145\u20138152. doi: 10.1523/JNEUROSCI.18-20-08145.1998.", "ArticleIdList": ["10.1523/JNEUROSCI.18-20-08145.1998", "PMC6792836", "9763461"]}, {"Citation": "Anjaneyulu J., Vidyashankar R., Godbole A. Differential effect of Ayurvedic nootropics on C. elegans models of Parkinson\u2019s disease. Ayurveda Integr. Med. 2020;11:440\u2013447. doi: 10.1016/j.jaim.2020.07.006.", "ArticleIdList": ["10.1016/j.jaim.2020.07.006", "PMC7772502", "32978047"]}, {"Citation": "Akhoon B.A., Pandey S., Tiwari S., Pandey R. Withanolide A offers neuroprotection, ameliorates stress resistance and prolongs the life expectancy of Caenorhabditis elegans. Exp. Gerontol. 2016;78:47\u201356. doi: 10.1016/j.exger.2016.03.004.", "ArticleIdList": ["10.1016/j.exger.2016.03.004", "26956478"]}, {"Citation": "Gupta G., Avtar C. Synergistic effect of Withania somnifera dunal and L-dopa in the inhiition of haloperidol-induced catalepsy in mice. Pharmacogn. Mag. 2009;5:46\u201350."}, {"Citation": "Prakash J., Yadav S.K., Chouhan S., Prakash S., Singh S.P. Synergistic effect of Mucuna pruriens and Withania somnifera in a paraquat induced Parkinsonian mouse model. Adv. Biosci. Biotechnol. 2013;4:1\u20139. doi: 10.4236/abb.2013.411A2001.", "ArticleIdList": ["10.4236/abb.2013.411A2001", "0"]}, {"Citation": "Maheswari T., Dhanraj V., Natchiyar R., Kalaivani K., Raja Sankar S., Tamilselvam K., Manivasagam T. Synergistic neuropreventive effect of Withania somnifera root powder and mucuna pruriens seed powder in parkinsonic mice model. Herb. Med. Toxicol. 2010;4:63\u201369."}, {"Citation": "Yadav S.K., Prakash J., Chouhan S., Singh S.P. Mucuna pruriens seed extract reduces oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in paraquat-induced Parkinsonian mouse model. Neurochem. Int. 2013;62:1039\u20131047. doi: 10.1016/j.neuint.2013.03.015.", "ArticleIdList": ["10.1016/j.neuint.2013.03.015", "23562769"]}, {"Citation": "Vegh C., Wear D., Okaj I., Huggard R., Culmone L., Eren S., Cohen J., Rishi A.K., Pandey S. Combined Ubisol-Q(10) and Ashwagandha Root Extract Target Multiple Biochemical Mechanisms and Reduces Neurodegeneration in a Paraquat-Induced Rat Model of Parkinson\u2019s Disease. Antioxidants. 2021;10:563. doi: 10.3390/antiox10040563.", "ArticleIdList": ["10.3390/antiox10040563", "PMC8067369", "33917328"]}, {"Citation": "MacDonald M.E., Ambrose C.M., Duyao M.P., Myers R.H., Lin C., Srinidhi L., Barnes G., Taylor S.A., James M., Groot N., et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72:971\u2013983. doi: 10.1016/0092-8674(93)90585-E.", "ArticleIdList": ["10.1016/0092-8674(93)90585-E", "8458085"]}, {"Citation": "DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;277:1990\u20131993. doi: 10.1126/science.277.5334.1990.", "ArticleIdList": ["10.1126/science.277.5334.1990", "9302293"]}, {"Citation": "Papoutsi M., Labuschagne I., Tabrizi S.J., Stout J.C. The cognitive burden in Huntington\u2019s disease: Pathology, phenotype, and mechanisms of compensation. Mov. Disord. Off. J. Mov. Disord. Soc. 2014;29:673\u2013683. doi: 10.1002/mds.25864.", "ArticleIdList": ["10.1002/mds.25864", "24757115"]}, {"Citation": "Kaur N., Kumar P., Jamwal S., Deshmukh R., Gauttam V. Tetrabenazine: Spotlight on Drug Review. Ann. Neurosci. 2016;23:176\u2013185. doi: 10.1159/000449184.", "ArticleIdList": ["10.1159/000449184", "PMC5043267", "27721587"]}, {"Citation": "Kumar P., Kumar A. Effects of root extract of Withania somnifera in 3-Nitropropionic acid-induced cognitive dysfunction and oxidative damage in rats. Int. J. Health Res. 2008;1:139\u2013149. doi: 10.4314/ijhr.v1i3.55359.", "ArticleIdList": ["10.4314/ijhr.v1i3.55359"]}, {"Citation": "Kumar P., Kumar A. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington\u2019s disease. J. Med. Food. 2009;12:591\u2013600. doi: 10.1089/jmf.2008.0028.", "ArticleIdList": ["10.1089/jmf.2008.0028", "19627208"]}, {"Citation": "Joshi T., Kumar V., Kaznacheyeva E.V., Jana N.R. Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington\u2019s Disease. Mol. Neurobiol. 2021;58:3992\u20134006. doi: 10.1007/s12035-021-02397-8.", "ArticleIdList": ["10.1007/s12035-021-02397-8", "33904021"]}, {"Citation": "Venkatramaniah C., Praba A. A Study on the Behaviour of Huntington\u2019s Chorea Rat Models on Rotarod: Treated with Withanolide a and the Ethanolic Extract of Withania somnifera. Int. J. Anat. Res. 2015;3:1510\u20131514. doi: 10.16965/ijar.2015.286.", "ArticleIdList": ["10.16965/ijar.2015.286"]}, {"Citation": "Gandhi J., Antonelli A.C., Afridi A., Vatsia S., Joshi G., Romanov V., Murray I.V.J., Khan S.A. Protein misfolding and aggregation in neurodegenerative diseases: A review of pathogeneses, novel detection strategies, and potential therapeutics. Rev. Neurosci. 2019;30:339\u2013358. doi: 10.1515/revneuro-2016-0035.", "ArticleIdList": ["10.1515/revneuro-2016-0035", "30742586"]}, {"Citation": "Casas C., Herrando-Grabulosa M., Manzano R., Mancuso R., Osta R., Navarro X. Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav. 2013;3:145\u2013158. doi: 10.1002/brb3.104.", "ArticleIdList": ["10.1002/brb3.104", "PMC3607155", "23531559"]}, {"Citation": "Swarup V., Phaneuf D., Dupr\u00e9 N., Petri S., Strong M., Kriz J., Julien J.P. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor \u03baB-mediated pathogenic pathways. J. Exp. Med. 2011;208:2429\u20132447. doi: 10.1084/jem.20111313.", "ArticleIdList": ["10.1084/jem.20111313", "PMC3256969", "22084410"]}, {"Citation": "Patel P., Julien J.P., Kriz J. Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12:217\u2013233. doi: 10.1007/s13311-014-0311-0.", "ArticleIdList": ["10.1007/s13311-014-0311-0", "PMC4322065", "25404049"]}, {"Citation": "Dutta K., Patel P., Julien J.P. Protective effects of Withania somnifera extract in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 2018;309:193\u2013204. doi: 10.1016/j.expneurol.2018.08.008.", "ArticleIdList": ["10.1016/j.expneurol.2018.08.008", "30134145"]}, {"Citation": "Khan S., Rammeloo A.W., Heikkila J.J. Withaferin A induces proteasome inhibition, endoplasmic reticulum stress, the heat shock response and acquisition of thermotolerance. PLoS ONE. 2012;7:e50547. doi: 10.1371/journal.pone.0050547.", "ArticleIdList": ["10.1371/journal.pone.0050547", "PMC3511540", "23226310"]}, {"Citation": "Hahm E.R., Singh S.V. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells. Curr. Cancer Drug Targets. 2013;13:640\u2013650. doi: 10.2174/15680096113139990039.", "ArticleIdList": ["10.2174/15680096113139990039", "PMC3723758", "23607597"]}, {"Citation": "Swarup V., Phaneuf D., Bareil C., Robertson J., Rouleau G.A., Kriz J., Julien J.P. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain J. Neurol. 2011;134:2610\u20132626. doi: 10.1093/brain/awr159.", "ArticleIdList": ["10.1093/brain/awr159", "21752789"]}, {"Citation": "Dutta K., Patel P., Rahimian R., Phaneuf D., Julien J.P. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration. Neurotherapeutics. 2017;14:447\u2013462. doi: 10.1007/s13311-016-0499-2.", "ArticleIdList": ["10.1007/s13311-016-0499-2", "PMC5398980", "27928708"]}, {"Citation": "Beaulieu J.-M., Jacomy H., Julien J.-P. Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. J. Neurosci. 2000;20:5321\u20135328. doi: 10.1523/JNEUROSCI.20-14-05321.2000.", "ArticleIdList": ["10.1523/JNEUROSCI.20-14-05321.2000", "PMC6772336", "10884316"]}, {"Citation": "Beaulieu J.-M., Nguyen M.D., Julien J.-P. Late onset death of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 1999;147:531\u2013544. doi: 10.1083/jcb.147.3.531.", "ArticleIdList": ["10.1083/jcb.147.3.531", "PMC2151189", "15132161"]}, {"Citation": "Choudhary D., Bhattacharyya S., Bose S. Efficacy and safety of Ashwagandha (Withania somnifera (L.) Dunal) root extract in improving memory and cognitive functions. Diet. Suppl. 2017;14:599\u2013612. doi: 10.1080/19390211.2017.1284970.", "ArticleIdList": ["10.1080/19390211.2017.1284970", "28471731"]}, {"Citation": "Pingali U., Pilli R., Fatima N. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacogn. Res. 2014;6:12. doi: 10.4103/0974-8490.122912.", "ArticleIdList": ["10.4103/0974-8490.122912", "PMC3897003", "24497737"]}, {"Citation": "Xing D., Yoo C., Gonzalez D., Jenkins V., Nottingham K., Dickerson B., Leonard M., Ko J., Faries M., Kephart W., et al. Effects of Acute Ashwagandha Ingestion on Cognitive Function. Int. J. Environ. Res. Public Health. 2022;19:11852. doi: 10.3390/ijerph191911852.", "ArticleIdList": ["10.3390/ijerph191911852", "PMC9565281", "36231152"]}, {"Citation": "Visweswari G., Christopher R., Rajendra W. Withania somnifera against glutamate excitotoxicity and neuronal cell loss in a scopolamine-induced rat model of Alzheimer\u2019s disease. Eur. J. Biol. Res. 2021;11:156\u2013167. doi: 10.5281/zenodo.4426779.", "ArticleIdList": ["10.5281/zenodo.4426779"]}, {"Citation": "Ahmed M.E., Javed H., Khan M.M., Vaibhav K., Ahmad A., Khan A., Tabassum R., Islam F., Safhi M.M., Islam F. Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment. Protoplasma. 2013;250:1067\u20131078. doi: 10.1007/s00709-013-0482-2.", "ArticleIdList": ["10.1007/s00709-013-0482-2", "23340606"]}, {"Citation": "Ponticelli M., Lela L., Moles M., Mangieri C., Bisaccia D., Faraone I., Falabella R., Milella L. The healing bitterness of Gentiana lutea L., phytochemistry and biological activities: A systematic review. Phytochemistry. 2023;206:113518. doi: 10.1016/j.phytochem.2022.113518.", "ArticleIdList": ["10.1016/j.phytochem.2022.113518", "36423749"]}]}], "History": [{"Year": "2024", "Month": "2", "Day": "7"}, {"Year": "2024", "Month": "2", "Day": "28"}, {"Year": "2024", "Month": "3", "Day": "6"}, {"Year": "2024", "Month": "4", "Day": "9", "Hour": "18", "Minute": "43"}, {"Year": "2024", "Month": "4", "Day": "9", "Hour": "18", "Minute": "42"}, {"Year": "2024", "Month": "4", "Day": "9", "Hour": "12", "Minute": "6"}, {"Year": "2024", "Month": "3", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["38592845", "PMC10976061", "10.3390/plants13060771", "plants13060771"]}}]}